Esperion Therapeutics
ESPR
#6659
Rank
$0.81 B
Marketcap
$3.18
Share price
0.00%
Change (1 day)
125.53%
Change (1 year)

Esperion Therapeutics (ESPR) - Total liabilities

Total liabilities on the balance sheet as of March 2026 : $0.77 Billion USD

According to Esperion Therapeutics's latest financial reports the company's total liabilities are $0.77 Billion USD. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Esperion Therapeutics - Total liabilities on balance sheet (from 2001 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-12-31$0.76 B4.82%
2024-12-31$0.73 B10.86%
2023-12-31$0.66 B15.58%
2022-12-31$0.57 B-1.18%
2021-12-31$0.57 B28.74%
2020-12-31$0.44 B131.05%
2019-12-31$0.19 B202.33%
2018-12-31$64.33 M94.1%
2017-12-31$33.14 M99.53%
2016-12-31$16.61 M99.82%
2015-12-31$8.31 M-14.49%
2014-12-31$9.72 M131.31%
2013-12-31$4.2 M-82.99%
2012-12-31$24.7 M199.91%
2011-12-31$8.23 M
2002-12-31$12.66 M6.94%
2001-12-31$11.84 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Pfizer
PFE
$117.21 B 15,113.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
$9.44 B 1,125.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
$1.52 B 97.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
$65.96 M-91.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
$0.67 B-12.31%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
$2.37 B 208.76%๐Ÿ‡บ๐Ÿ‡ธ USA